ADHD medication tied to lower risk for alcohol, drug abuse in teens and adults

July 13, 2017, Indiana University
This study found a significant link between the use of ADHD medication and lowered risk for alcohol and drug abuse in teens and adults. Credit: Indiana University

The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.

The risk of substance use problems during periods of use was 35 percent lower in men and 31 percent lower in women in the study. The results, based upon nearly 3 million people with ADHD in the United States, are reported in the American Journal of Psychiatry.

"This study contributes to growing evidence that ADHD medication is linked to lower risk for many types of harmful behavior, including substance abuse," said Patrick D. Quinn, a postdoctoral researcher in the IU Bloomington College of Arts and Sciences' Department of Psychological and Brain Sciences, who led the study. "The results also highlight the importance of careful diagnosis and compliance with treatment."

As one of the largest analyses on the risks and benefits of ADHD medication, the study drew on anonymous health care data from 146 million people with employer-based health insurance in the United States from 2005 to 2014.

Specifically, the researchers mined the data to identify people with ADHD whose records showed periods of ADHD medication use and periods without ADHD medication use—as well as one or more visits to the due to drug or alcohol use. They then calculated the odds of the visits occurring during the person's use of ADHD medication versus the same person's non-use of ADHD medication.

"Many factors can influence who receives ADHD treatment, including socioeconomic factors, health care access, the strength of support networks and disorder severity," Quinn said. "Although no single study of real-world treatment practices can definitively show whether medication use lowers risk, studying the same people at different points in their medical history helps us control for these factors and isolate the role of medication in their behavior."

Of the nearly 3 million people with ADHD in the study's database, about 57 percent experienced periods in which they were and were not prescribed medication to treat the disorder. About 2 percent experienced an emergency room visit due to . The median age of the study's participants was 21 for men and 28 for women.

The majority of the ADHD medicines used in the study were stimulants such as Adderall, an amphetamine, and Ritalin, or methylphenidate. A significantly smaller number used nonstimulant ADHD medication such as Strattera, or atomoxetine.

"While concerns about prescribing medications to treat ADHD that have the potential for abuse are understandable, this study provides further evidence that the use of these medications is not associated with increased risk of substance use problems in adolescence or adulthood," Quinn said. "Rather, this and other recent studies find that the risk of such problems is lower during and after periods of use of these medications."

Quinn is a member of the lab of Brian M. D'Onofrio, a professor in the Department of Psychological and Brain Sciences. Another study from this group recently reported in JAMA Psychiatry found that the use of ADHD medication was associated with lower risk of motor vehicle accidents in men and women.

D'Onofrio is also a co-author of several studies based on patient data from Sweden that found similarly lower risk for substance abuse and transport accidents in people with ADHD who used medication.

The larger number of people in the two more recent studies—as well as the use of U.S. patients in the new analyses—strengthens this earlier evidence.

"Together, these studies provide accumulating evidence about the possible short- and long-term benefits of ADHD medications," D'Onofrio said. "They also provide important information to medical providers who prescribe ADHD medication—as well as to adults with the disorder and parents trying to make medical decisions for children. Overall, I think people should find these results reassuring."

Explore further: ADHD medication associated with reduced risk for motor vehicle crashes

More information: Patrick D. Quinn et al, ADHD Medication and Substance-Related Problems, American Journal of Psychiatry (2017). DOI: 10.1176/appi.ajp.2017.16060686

Related Stories

ADHD medication associated with reduced risk for motor vehicle crashes

May 10, 2017
In a study of more than 2.3 million patients in the United States with attention-deficit/hyperactivity disorder (ADHD), rates of motor vehicle crashes (MVCs) were lower when they had received their medication, according to ...

Licensing, motor vehicle crash risk among teens with ADHD

June 12, 2017
Adolescents with attention-deficit/hyperactivity disorder (ADHD) are licensed to drive less often and, when this group is licensed, they have a greater risk of crashing, according to a new study published by JAMA Pediatrics.

Study highlights multiple factors of ADHD medication use

June 8, 2016
Youth who take Ritalin, Adderall or other stimulant medications for ADHD over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a University ...

Children with ADHD prone to substance use disorders

July 1, 2014
(HealthDay)—Screening for substance use disorders (SUDs) and the safe use of stimulant medications are important issues in the care of children with attention-deficit/hyperactivity disorder (ADHD), according to research ...

Do ADHD medicines boost substance abuse risk?

July 15, 2016
(HealthDay)—Parents often worry that their children who take stimulants to treat attention deficit hyperactivity disorder (ADHD) may be at higher risk for substance abuse later.

Most ADHD medicine used by December-born children

June 9, 2017
Children born at the end of the year are more likely to receive ADHD medication or an ADHD diagnosis than children born early in the year. This is according to a new study from the Norwegian Institute of Public Health.

Recommended for you

ADHD may increase risk of Parkinson's disease and similar disorders

September 12, 2018
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD medications remains understudied. ...

Over past 20 years, percentage of children with ADHD nearly doubles

September 3, 2018
The number of children diagnosed with attention deficit hyperactivity disorder has reached more than 10 percent, a significant increase during the past 20 years, according to a study released Friday.

ADHD rates rising sharply in US kids

August 31, 2018
(HealthDay)—The number of ADHD diagnoses among children has risen dramatically in the past two decades, going from 6 percent to 10 percent, a new report shows.

Study identifies distinct origin of ADHD in children with history of brain injury

August 14, 2018
According to a study in Biological Psychiatry, physical brain injury in children contributes to the development of attention-deficit/hyperactivity disorder (ADHD), distinct from genetic risk for the disorder.

New research suggests how stimulant treatments for ADHD work

July 27, 2018
Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). In the classroom, parents and teachers say that medications like methylphenidate (MPH) can reduce symptoms and improve ...

After-school programs a blessing for kids with ADHD

May 8, 2018
(HealthDay)—After-school activities might be just what the doctor ordered for kids with attention-deficit/hyperactivity disorder (ADHD), researchers suggest.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Captain Stumpy
1 / 5 (1) Jul 14, 2017
@idiot pseudoscience crackpot quack
ADHD can be cured by taking 250mg of healthy adult human male facial skin surface lipid liquid pheromone.
repeating a fraudulent claim doesn't make it more true

there is still absolutely no scientific evidence supporting this claim whatsoever

point of fact, you can't even provide a singular study published in a reputable peer reviewed journal that supports your claims

you're still a fraud

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.